Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 11/20 | 0.39 |
| ▸ | MGLL | Q99685 | 6/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.32 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5037159 | 1.00 | FAAH (0.39) | FAAHMGLLALDH1A1NPSR1HSP90AA1 | |
| SCHEMBL5805436 | 0.88 | ALDH1A1 (0.34) | FAAHALDH1A1NPSR1HSP90AA1HPGD | |
| SCHEMBL24393467 | 0.85 | FAAH (0.31) | FAAHMGLL | |
| SCHEMBL27634428 | 0.85 | FAAH (0.32) | FAAHMGLL | |
| SCHEMBL18353699 | 0.85 | NAAA (0.38) | FAAHMGLLTDP1SMN1; SMN2 | |
| SCHEMBL10032833 | 0.84 | FAAH (0.44) | FAAHMGLLALDH1A1NPSR1HSP90AA1 | |
| SCHEMBL15080490 | 0.82 | FAAH (0.40) | FAAHMGLLALDH1A1NPSR1HSP90AA1 | |
| SCHEMBL157132 | 0.82 | MGLL (0.37) | FAAHMGLL | |
| SCHEMBL9055859 | 0.82 | MGLL (0.37) | FAAHMGLL | |
| SCHEMBL43979 | 0.80 | MGLL (0.48) | FAAHMGLLALDH1A1NPSR1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3255 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4648791-A1 | POLYMERIZED HEMOGLOBIN SIZE FRACTIONATED VIA TANGENTIAL FLOW FILTRATION | Ohio State Innovation Foundation (US) | 2025-11-19 | — | — | EP | claimed |
| EP-4642491-A1 | METHOD FOR GLYCOPROTEIN MODIFICATION | Honeybear Biosciences Inc. (TW) | 2025-11-05 | — | — | EP | claimed |
| WO-2025091021-A1 | POLYMERIZED ALBUMIN AND METHODS OF MAKING AND USING THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2025-05-01 | — | — | WO | claimed |
| WO-2025091017-A1 | SYNTHETIC WHOLE BLOOD SUBSTITUTES | OHIO STATE INNOVATION FOUNDATION (US) | 2025-05-01 | — | — | WO | claimed |
| US-20240294609-A1 | STABILIZED HEMOGLOBIN COMPOSITIONS AND PHARMACEUTICAL FORMULATIONS THEREOF | GOLD BLAZE, LTD. (SG) | 2024-09-05 | — | — | US | claimed |
| US-20240238432-A1 | METHOD FOR GLYCOPROTEIN MODIFICATION | HONEYBEAR BIOSCIENCES INC. (TW) | 2024-07-18 | — | — | US | claimed |
| WO-2024151999-A1 | POLYMERIZED HEMOGLOBIN SIZE FRACTIONATED VIA TANGENTIAL FLOW FILTRATION | OHIO STATE INNOVATION FOUNDATION (US) | 2024-07-18 | — | — | WO | claimed |
| WO-2024145600-A1 | METHOD FOR GLYCOPROTEIN MODIFICATION | HONEYBEAR BIOSCIENCES INC. (TW) | 2024-07-04 | — | — | WO | claimed |
| US-11712423-B2 | Methods and compositions for modifying mucous membranes | ABBOTT NICHOLAS L (US) | 2023-08-01 | — | — | US | claimed |
| CN-115996942-A | Macrophage-targeting peptides, conjugates, compositions and uses thereof | 双亥生命科学株式会社 | 2023-04-21 | — | — | CN | claimed |
| EP-0675737-A1 | IMMUNOREACTIVE REAGENTS EMPLOYING DIHYDROFOLATE REDUCTASE | THE WELLCOME FOUNDATION LIMITED (GB) | 1995-10-11 | — | — | EP | claimed |
| US-5399501-A | Covalent attachment of specific binding members to a solid phase with two bifunctional reagents and a dithio compound | ABBOTT LABORATORIES (US) | 1995-03-21 | — | — | US | claimed |
| WO-1994029333-A1 | IMMUNOREACTIVE REAGENTS EMPLOYING MONOAMINE OXIDASE | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-12-22 | — | — | WO | claimed |
| WO-1994020523-A1 | TUMOR TARGETING WITH L-ENANTIOMERIC OLIGONUCLEOTIDE CONJUGATES OF IMMUNOREAGENTS AND OF CHELATED RADIONUCLIDES | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-09-15 | — | — | WO | claimed |
| WO-1994016741-A1 | IMMUNOREACTIVE REAGENTS EMPLOYING HETERODIMERS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-08-04 | — | — | WO | claimed |
| WO-1994013327-A1 | IMMUNOREACTIVE REAGENTS EMPLOYING DIHYDROFOLATE REDUCTASE | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-06-23 | — | — | WO | claimed |
| WO-1994012216-A1 | SEQUENTIAL TARGETING OF TUMOR SITES WITH OLIGONUCLEOTIDE CONJUGATES OF ANTIBODY AND COMPLEMENTARY OLIGONUCLEOTIDE CONJUGATES OF CHELATED RADIONUCLIDE | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-06-09 | — | — | WO | claimed |
| EP-0396116-A2 | Covalent attachment of specific binding members to a solid phase | ABBOTT LABORATORIES (US) | 1990-11-07 | — | — | EP | claimed |
| US-4657853-A | Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-14 | — | — | US | claimed |
| EP-0175560-A2 | Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-03-26 | — | — | EP | claimed |